Kikuchi Miki, Ohtani Toshihiro, Tamura Tomohiro, Satoh Hiroaki
Division of Nursing, Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310-0015, Japan.
Division of Pharmacy, Mito Medical Center, University of Tsukuba, Mito, Ibaraki 310-0015, Japan.
Mol Clin Oncol. 2016 Nov;5(5):651-652. doi: 10.3892/mco.2016.1026. Epub 2016 Sep 21.
Pulmonary sulcus tumors are occasionally encountered in non-small-cell lung cancer (NSCLC) patients. If the patients have a good clinical condition, concurrent chemoradiotherapy is indicated. However, palliative chemotherapy and chemoradiotherapy for patients exhibiting a poor overall condition have not been reported to date. We herein report the case of a 54-year-old female patient with a pulmonary sulcus tumor, who had a poor performance status. The patient received sequential chemoradiotherapy, with no severe complications. There was no local recurrence until the time of death, 8 months after the initiation of therapy. Palliative sequential chemoradiotherapy for pulmonary sulcus NSCLC must be effective and carry low risk of complications. Palliative sequential chemoradiotherapy may be considered in certain patients with pulmonary sulcus NSCLC. Either chemotherapy or radiotherapy is administered first and, if there is no apparent deterioration of the patient's general condition, the next treatment modality is administered.
肺沟瘤在非小细胞肺癌(NSCLC)患者中偶尔可见。如果患者临床状况良好,建议进行同步放化疗。然而,迄今为止,尚未见有关全身状况较差患者的姑息化疗及放化疗的报道。我们在此报告1例54岁肺沟瘤女性患者,其体能状态较差。该患者接受了序贯放化疗,未出现严重并发症。直至治疗开始8个月后死亡时,均无局部复发。对于肺沟瘤NSCLC患者,姑息性序贯放化疗必须有效且并发症风险低。对于某些肺沟瘤NSCLC患者,可考虑采用姑息性序贯放化疗。先给予化疗或放疗,如果患者一般状况无明显恶化,则给予下一种治疗方式。